ClinicalTrials.gov
ClinicalTrials.gov Menu

Raltegravir Treatment in Patients Failing Highly Active Antiretroviral Therapy (HAART) in Denmark

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01061957
Recruitment Status : Completed
First Posted : February 3, 2010
Last Update Posted : February 4, 2010
Sponsor:
Collaborator:
Merck Sharp & Dohme Corp.
Information provided by:
Rigshospitalet, Denmark

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : July 2009
  Actual Study Completion Date : December 2009